Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04004403 · ClinicalTrials.gov registry record · NA
Alternate Day Fasting, Exercise, and NAFLD
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT04004403 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 80 participants.
The verdict
NCT04004403, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Approximately 65% of obese individuals have non-alcoholic fatty liver disease (NAFLD), and this condition is strongly related to the development of insulin resistance and diabetes. Innovative lifestyle strategies to treat NAFLD are critically needed. The proposed research will demonstrate that alternate day fasting (ADF) combined with exercise is an effective non-pharmacological therapy to treat NAFLD.
Interventions
- OTHER Exercise
- OTHER Alternate day fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04004403
The ClinicalTrials.gov registry entry for NCT04004403 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.
NCT04004403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04004403 about?
NCT04004403 is a clinical study titled "Alternate Day Fasting, Exercise, and NAFLD". Approximately 65% of obese individuals have non-alcoholic fatty liver disease (NAFLD), and this condition is strongly related to the development of insulin resistance and diabetes. Innovative lifestyle strategies to treat NAFLD are critically needed. The proposed research will demonstrate that alter...
What is the current status of trial NCT04004403?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-09-01. Estimated completion is 2024-05-01.
What interventions are being tested in trial NCT04004403?
The interventions under investigation include: Exercise (OTHER), Alternate day fasting (OTHER).
Who is sponsoring clinical trial NCT04004403?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.